We encourage work that introduces new ideas, concepts, research and understandings to the field, as well as analysis of both success and failure. Please read the following guidelines carefully before submitting your abstract:
- Abstracts can only be submitted online via the conference website; submissions by fax, post or e-mail will not be considered.
- Abstracts must be written in English.
- The abstract text body is limited to a maximum of 400 words. Titles are limited to 30 words.
- A maximum of one table and one graph/image (in JPG, GIF, TIFF or PNG with ideally 600 dpi, a minimum size of 500 KB and a maximum size of 10 MB) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups.
- Abstracts should be structured and include concise statements outlining:
- Background – study objectives, hypothesis to be tested, or description of the problem
- Methods – method(s) used or approach taken
- Results – present as clearly and as much in detail as possible the findings/outcome of the study. Please summarise any specific results (incl. statistical analysis when appropriate)
- Conclusion – description of the main outcome of the study, and explain the significance of your findings, and future implications of the results.
- Authors are strongly encouraged to provide proper quantification of experimental results in the form of an illustrative table or figure.
- It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
- The abstract theme is the general heading under which your abstract will be reviewed. Please choose the theme which best suits the subject of your abstract: Pathogenesis, Epidemiology, Treatment, or Prevention.
If you have any questions regarding your abstract submission, please contact the registration office at firstname.lastname@example.org, phone +31 20 57273 15.
- Work that has been previously published or presented at a national, regional or international meeting preferably should only be submitted provided that new findings and/or updated information is included.
- If preliminary or partial data have been published or presented previously, the submitting author will be required to provide details of the publication or presentation, along with a justification of why the abstract merits consideration for NCHIV 2017. This information will be considered by the Scientific Programme Committee when making final decisions.
- If the author neglects to provide these required details and justification, or if evidence of previous publication or presentation is found without new and/or updated information, the abstract will be rejected.
- Previously-published or previously-presented work will be stringently assessed and, under most circumstances, only accepted as a poster presentation.
Rule of two
Each author may present a maximum of two abstracts at the conference. The number of submissions, however, is not limited. Should an author have more than two abstracts accepted for presentation, a co-author must be named as presenting author for one or more abstracts.
Deadline for abstract submission
Abstracts must be submitted before Thursday 7 September 2017, 5 PM (17:00, GMT+1). Abstracts submitted after this time will not be considered.
After submission of the abstract, the submitting author will receive a confirmation email. If you do not receive a confirmation email, please contact us at email@example.com.
All submitted abstracts go through a blinded peer-review process carried out by selected expert reviewers. The following criteria will be considered by the reviewers:
- Is there a clear background and justified objective?
- Is the methodology or design appropriate for the objectives?
- Are the results important and clearly presented?
- Are the conclusions supported by the results?
- Is the study original, and does it contribute to the field?
The scientific programme committee will make the final selection of abstracts for inclusion in the conference programme. Abstracts can be selected for oral presentation during one of the four plenary sessions or for presentation as a poster.
Notification of acceptance or rejection
Notification of acceptance or rejection will be sent to the submitting author by mid October 2017. Please note that the submitting author who receives this notification email is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.
All NCHIV participants will receive the abstract book, which includes all accepted abstracts and the final programme. The abstract book will also be published on the NCHIV website. In addition, all oral and poster presentations will be published on the NCHIV website, providing author approval has been granted.
Presenting authors are also required to register separately for the conference. For registration, please go to www.nchiv.org.
Joep Lange & Jacqueline van Tongeren Junior Investigator’s Award
This year the scientific programme committee will once again select the best abstract submitted by a junior scientist to be awarded the Joep Lange & Jacqueline van Tongeren Junior Investigator’s Award.
To be considered for the award, authors must be in the process of gaining or have recently gained their PhD. In addition, the abstract must relate to work carried out in gaining their PhD.
The winning abstract author will be given the opportunity to present their abstract as an oral presentation during one of the conference sessions. They will also receive a prize to the value of €1000 to be spent on a study or conference trip of their choice.
The winning author will be announced during the final conference session.